C&C International Co., Ltd. (KOSDAQ:352480)
22,000
+1,400 (6.80%)
At close: Jun 29, 2026
C&C International Revenue
C&C International had revenue of 70.84B KRW in the quarter ending March 31, 2026, with 7.36% growth. This brings the company's revenue in the last twelve months to 293.33B, up 6.01% year-over-year. In the year 2025, C&C International had annual revenue of 288.48B with 1.98% growth.
Revenue (ttm)
293.33B
Revenue Growth
+6.01%
P/S Ratio
1.02
Revenue / Employee
486.46M
Employees
603
Market Cap
299.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 288.48B | 5.59B | 1.98% |
| Dec 31, 2024 | 282.88B | 62.56B | 28.39% |
| Dec 31, 2023 | 220.33B | 89.72B | 68.70% |
| Dec 31, 2022 | 130.61B | 39.31B | 43.06% |
| Dec 31, 2021 | 91.29B | 1.68B | 1.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmecca Korea | 707.71B |
| CLIO Cosmetics Co.,Ltd | 324.92B |
| Englewood Lab | 224.00B |
| Manyo Factory | 113.06B |
| Newtree | 101.37B |
| Icure Pharmaceutical Incorporation | 93.45B |
| Genic | 89.73B |
| Coreana Cosmetics | 73.22B |